(Q34343282)

1 August 2017

1 reference

title

The toxicology of perfluorooctanoate (English)

1 reference

1 August 2017

Gerald L Kennedy

1

1 reference

1 August 2017

John L Butenhoff

2

1 reference

1 August 2017

Geary W Olsen

3

1 reference

1 August 2017

John C O'Connor

4

1 reference

1 August 2017

Andrew M Seacat

5

1 reference

1 August 2017

Roger G Perkins

6

1 reference

1 August 2017

Lisa B Biegel

7

1 reference

1 August 2017

Sandra R Murphy

8

1 reference

1 August 2017

David G Farrar

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Critical Reviews in Toxicology

1 August 2017

1 reference

1 August 2017

34

1 reference

1 August 2017

4

1 reference

1 August 2017

351-384

1 reference

The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator

1 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens and metabolic modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Hepatic peroxisome proliferation in rodents and its significance for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Characterization of risk for general population exposure to perfluorooctanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Rodent Leydig cell tumorigenesis: a review of the physiology, pathology, mechanisms, and relevance to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Tissue-specific induction of 17 beta-hydroxysteroid dehydrogenase type IV by peroxisome proliferator chemicals is dependent on the peroxisome proliferator-activated receptor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Mortality among employees of a perfluorooctanoic acid production plant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Effect of undernutrition and amino acid deficiency on the timing of puberty in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

PPAR: a mediator of peroxisome proliferator action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Animal toxicity studies with ammonium perfluorooctanoate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Binding of perfluorooctanoic acid to rat and human plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Elimination and toxicity of perfluorooctanoic acid during subchronic administration in the Wistar rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Body weight and food intake as initiating factors for puberty in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Dermal toxicity of ammonium perfluorooctanoate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Increase in mouse liver weight following feeding of ammonium perfluorooctanoate and related fluorochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

PPARalpha agonist-induced rodent tumors: modes of action and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Sex hormone-regulated renal transport of perfluorooctanoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Sexual maturation data for Crl Sprague-Dawley rats: criteria and confounding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

On the mechanism of the hepatocarcinogenicity of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Rhabdomyolysis and HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Malignant Tumors in Rats Fed Nafenopin, a Hepatic Peroxisome Proliferator 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Undernutrition, puberty and the development of estrogen positive feedback in the female rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Structural determinants of fluorochemical-induced mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte Cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Evidence that there are Two Forms of Fluoride in Human Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

Electrophoretic Mobility of Serum Fluoride

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440490464705

10.1080/10408440490464705

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference